finance.yahoo.com ·
Cvs Health Cvs Price Target
Topic context
This topic has been covered 243093 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedCVS Health (NYSE:CVS) received a modest price target increase from Wells Fargo after strong Q1 results and raised guidance. The commercial mechanism is a positive earnings surprise and improved outlook for a major US healthcare and pharmacy retailer. Impact is company-specific, not sector-wide; no supply chain or commodity price channel. Weak commercial mechanism beyond the equity analyst upgrade.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Wells Fargo raised CVS price target from $102 to $103, implying >13% upside.
- CVS Q1 2026 earnings and revenue beat estimates.
- CVS raised full-year 2026 profit guidance to $7.30-$7.50 per share (from $7-$7.20).
- CVS projects 2026 total revenues of at least $405 billion.
- Annual dividend yield is 2.88%.
Related stories
finance.yahoo.com
Health Tech Q1 2026 Earnings
finance.yahoo.com
Manulife Financial Q1 Earnings Call
finance.yahoo.com
Ncmi Q1 2026 Earnings Transcript
finance.yahoo.com
Nextera Dominion Energy Merger Create
economictimes.indiatimes.com